Stockscreener 앱 받기
10.94
7.91%
-0.9401
시간 외 거래:
10.94
0.000100
+0.00%
Surrozen Inc 주식(SRZN)의 최신 뉴스
Surrozen partners with TCGFB for lung disease therapy - Investing.com
Surrozen partners with TCGFB for lung disease therapy By Investing.com - Investing.com UK
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - The Manila Times
StemPoint Capital LP Increases Stake in Surrozen Inc - GuruFocus.com
Trend Tracker for (SRZN) - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Trading Up 4.3% – Here’s What Happened - Defense World
How To Trade (SRZN) - Stock Traders Daily
This Week's Bay Area Deal Sheet (October 10, 2024) - Bisnow
Trading (SRZN) With Integrated Risk Controls - Stock Traders Daily
Surrozen extends South San Francisco headquarters lease By Investing.com - Investing.com Australia
Surrozen extends South San Francisco headquarters lease - Investing.com India
187,206 Shares in Surrozen, Inc. (NASDAQ:SRZN) Purchased by Nantahala Capital Management LLC - Defense World
Stonepine Capital Management LLC Invests $724,000 in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
CVI Holdings LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
Column Group LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZNW) - Defense World
Boehringer Ingelheim to advance SZN-413 for retinal diseases - BioWorld Online
Patrick Brennan joins Selective Insurance as CFO - Reinsurance News
Surrozen and Boehringer Ingelheim advance SZN-413 development By Investing.com - Investing.com South Africa
Streamline Health CEO buys $1,008 in company stock By Investing.com - Investing.com UK
Selective Insurance appoints Patrick Brennan as chief financial officer - ROI-NJ.com
Surrozen and Boehringer Ingelheim advance SZN-413 development - Investing.com India
Surrozen earns $10M milestone payment in Retinal Diseases collaboration - TipRanks
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration - GlobeNewswire
SThree Q3 net fees slip 8% amid challenging conditions - Staffing Industry Analysts
FINANCIALS: SThree reports 8% drop due to challenging conditions - Recruiter
Sagefield Capital LP Invests $2.35 Million in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Selective taps Progressive’s Brennan to fill CFO role on permanent basis - Re-Insurance.com
Recruiter SThree holds guidance despite ‘challenging’ market conditions - City A.M.
Selective lands Progressive’s Brennan as CFO, one year after Wilcox exit - Insurance Insider US
Selective Insurance Appoints Patrick S. Brennan as Chief Financial Officer - StockTitan
Plenham Limited statement: Jason Moseley - Bodyshop Magazine
Surrozen (NASDAQ:SRZN) Shares Up 2.4% - Defense World
(SRZN) Investment Analysis - Stock Traders Daily
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.60% - MSN
How to Take Advantage of moves in (SRZN) - Stock Traders Daily
Head to Head Comparison: 4D Molecular Therapeutics (NASDAQ:FDMT) vs. Surrozen (NASDAQ:SRZN) - Defense World
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Simply Wall St
SRZN Stock Earnings: Surrozen Misses EPS for Q2 2024 - InvestorPlace
Surrozen Provides Second Quarter 2024 Financial Results and Business Update - GlobeNewswire
Surrozen (NASDAQ:SRZN) and AIM ImmunoTech (NYSE:AIM) Head-To-Head Comparison - Defense World
Surrozen (NASDAQ:SRZN) Stock Price Up 1.3% - Defense World
(SRZN) Trading Report - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Stock Price Down 10.4% - Defense World
Surrozen announces director resignation - Investing.com India
Surrozen Announces Tim Kutzkey’s Board Resignation - TipRanks
(SRZN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
SRZNSurrozen, Inc. Latest Stock News & Market Updates - StockTitan
How the (SRZN) price action is used to our Advantage - Stock Traders Daily
Board of Trustees of The Leland Stanford Junior University Has $490000 Stock Holdings in Surrozen, Inc. (NASDAQ ... - Defense World
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique - EIN News
Surrozen Publishes Study in 'eLife' Demonstrating the - GlobeNewswire
Surrozen Publishes Study in 'eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique ... - StockTitan
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling - GlobeNewswire
Surrozen reports positive Phase 1a trial results for liver therapy - Investing.com India
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com - Investing.com Australia
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a ... - Investing News Network
2.02%
0.47%
자본화:
|
볼륨(24시간):